Mobile health support for pulmonary arterial hypertension
Part of Lungs & breathing clinical trials.
This study tests whether using a mobile health tool can help people with pulmonary arterial hypertension (PAH) manage their condition in daily life. It’s aimed at adults who are stable on their PAH medicines and can track activity using a wearable device.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult age 18 or older
- You have PAH caused by idiopathic, inherited, or related conditions (like connective tissue disease, certain drugs/toxins, or a simple birth heart defect such as an atrial septal defect)
- Your PAH is mild to moderate right now (WHO functional class I, II, or III), not class IV
- Your PAH medicines have been stable for 3 months (usually with no more than 1 diuretic change in that time)
- You can do normal daily activities without being wheelchair/bed-bound and without activity-limiting medical problems (your team must consider this)
- You can use an activity tracker for your usual activities
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a smartphone app can help adolescents with pulmonary hypertension stay active and improve their health. If you are a teen with stable PH and can use an activity tracker, this study may be a good fit.
This study tests whether regular remote check-ins and guidance can help people with pulmonary arterial hypertension stick to their treatment plan. You would be followed by phone or video from University of Sao Paulo.
This trial tests an experimental drug called HS235 for people with pulmonary arterial hypertension (PAH), a condition of high blood pressure in the lungs. It aims to see if the drug can help improve symptoms and exercise ability.
This study tests whether a home-based exercise program, added to your regular medications, can help people who are newly diagnosed with pulmonary arterial hypertension feel better and improve their daily function.
This trial tests a supervised exercise program for people with pulmonary arterial hypertension (PAH), a type of high blood pressure in the lungs. It aims to see if regular exercise can improve your daily function and quality of life.
This study looks at how people with pulmonary arterial hypertension (PAH) and certain genetic risks cope and how their bodies respond over time. It may help researchers understand factors linked to better or worse outcomes, and how different people manage the condition.
Hear when a new Pulmonary Arterial Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.